Key facts
- MOR’s last known valuation is $8.7M (Dec 2023).
- It has raised $14.0M; the latest was Seed Round in Oct 2025.
- Notable investors include Techstars, LvlUp Ventures, Minnesota Department of Employment and Economic Development, P&G Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MOR
- ·The full record, as it builds
Funding rounds
No funding rounds for MOR are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MOR
Developer of a drug-free wearable skin patch designed to deal with ejaculation. The company has developed a wearable skin patch after clinical study research is intended to be a transdermal-based product that uses neuromodulation as a means of inhibiting the nerves of the penis, enabling men to restore confidence in sexual health by eliminating the embarrassment and frustration of premature ejaculation.
- Sector
- Healthcare
- HQ
- Hamel, MN, United States
- Founded
- 2017
- Employees
- 5
- Website
- morarimedical.com/
- Ownership
- Privately Held (backing)
MOR doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MOR shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MOR in its N-PORT filings yet. We sweep new filings monthly.